{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:15:26Z","timestamp":1795029326290,"version":"4.10.2"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.heliyon.2020.e03795","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T17:45:17Z","timestamp":1588009517000},"page":"e03795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2587-8672","authenticated-orcid":false,"given":"Camilla","family":"Ottesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schiodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Gotfredsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2020.e03795_bib1","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw - 2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J.\u00a0Oral Maxillofac. Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Canc. Treat Rev."},{"key":"10.1016\/j.heliyon.2020.e03795_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J.\u00a0Oral Maxillofac. Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.oooo.2014.12.024","article-title":"Dentoalveolar trauma and minor trauma as precipitating factors for medication-related osteonecrosis of the jaw (ONJ): a retrospective study of 149 consecutive patients from the Copenhagen ONJ Cohort","volume":"119","author":"Yazdi","year":"2015","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.heliyon.2020.e03795_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.oooo.2013.10.010","article-title":"Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system","volume":"117","author":"Schiodt","year":"2014","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.heliyon.2020.e03795_bib6","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00432-010-0907-7","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases","volume":"136","author":"Filleul","year":"2010","journal-title":"J.\u00a0Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2020.e03795_bib7","first-page":"1391","article-title":"Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw","volume":"35","author":"Khan","year":"2008","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.heliyon.2020.e03795_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1445-5994.2008.01824.x","article-title":"Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment","volume":"39","author":"Dickinson","year":"2009","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.heliyon.2020.e03795_bib9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","article-title":"Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs","volume":"142","author":"Hellstein","year":"2011","journal-title":"J.\u00a0Am. Dent. Assoc."},{"key":"10.1016\/j.heliyon.2020.e03795_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2011.08574.x","article-title":"Guidelines for supportive care in multiple myeloma 2011","volume":"154","author":"Snowden","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.heliyon.2020.e03795_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.heliyon.2020.e03795_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10354-016-0437-2","article-title":"[Position paper on medication-related osteonecrosis of the jaw (MRONJ)]","volume":"166","author":"Svejda","year":"2016","journal-title":"Wien Med. Wochenschr."},{"key":"10.1016\/j.heliyon.2020.e03795_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J.\u00a0Clin. Densitom."},{"key":"10.1016\/j.heliyon.2020.e03795_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.11005\/jbm.2015.22.4.151","article-title":"Medication related osteonecrosis of the jaw: 2015 position statement of the Korean society for bone and mineral research and the Korean association of oral and maxillofacial surgeons","volume":"22","author":"Kim","year":"2015","journal-title":"J.\u00a0Bone Metab."},{"key":"10.1016\/j.heliyon.2020.e03795_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","article-title":"Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw","volume":"35","author":"Yoneda","year":"2017","journal-title":"J.\u00a0Bone Miner. Metabol."},{"key":"10.1016\/j.heliyon.2020.e03795_bib16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/annonc\/mdn796","article-title":"The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network","volume":"20","author":"Terpos","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.heliyon.2020.e03795_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1479-666X(09)80062-0","article-title":"Management of patients at risk of bisphosphonate osteonecrosis in maxillofacial surgery units in the UK","volume":"7","author":"McLeod","year":"2009","journal-title":"Surgeon"},{"key":"10.1016\/j.heliyon.2020.e03795_bib18","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.bdj.2017.539","article-title":"Oral health management of patients at risk of medication-related osteonecrosis of the jaw","volume":"222","year":"2017","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.heliyon.2020.e03795_bib19","series-title":"International Prospective Register of Systematic Reviews","year":"2019"},{"key":"10.1016\/j.heliyon.2020.e03795_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e03795_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem. Med."},{"key":"10.1016\/j.heliyon.2020.e03795_bib22","unstructured":"G.S. Wells, D. O\u00b4Connel, J. Peterson, The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses, (2019). http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.heliyon.2020.e03795_bib23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.joms.2009.10.026","article-title":"Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction","volume":"68","author":"Saia","year":"2010","journal-title":"J.\u00a0Oral Maxillofac. Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bjoms.2011.08.004","article-title":"Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases","volume":"50","author":"Ferlito","year":"2012","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcms.2015.02.018","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction","volume":"43","author":"Bodem","year":"2015","journal-title":"J.\u00a0Cranio-Maxillofacial Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/hed.21708","article-title":"Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws","volume":"36","author":"Wutzl","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.heliyon.2020.e03795_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tripleo.2010.04.015","article-title":"The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw, Oral Surgery","volume":"111","author":"Wilde","year":"2011","journal-title":"Oral Med. Oral Pathol. Oral Radiol. Endodontology."},{"key":"10.1016\/j.heliyon.2020.e03795_bib28","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ijom.2012.05.012","article-title":"The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series","volume":"41","author":"Jabbour","year":"2012","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jcms.2012.01.005","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients","volume":"40","author":"Voss","year":"2012","journal-title":"J.\u00a0Cranio-Maxillofacial Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5125\/jkaoms.2014.40.5.206","article-title":"Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw","volume":"40","author":"Kim","year":"2014","journal-title":"J.\u00a0Korean Assoc. Oral Maxillofac. Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib31","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.joms.2015.01.008","article-title":"Surgical therapy for bisphosphonate-related osteonecrosis of the jaw: six-year experience of a single institution","volume":"73","author":"Lopes","year":"2015","journal-title":"J.\u00a0Oral Maxillofac. Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.oooo.2015.10.033","article-title":"Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III, Oral Surg","volume":"121","author":"Bodem","year":"2016","journal-title":"Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.heliyon.2020.e03795_bib33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jcms.2017.01.013","article-title":"Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ)","volume":"45","author":"Hoefert","year":"2017","journal-title":"J.\u00a0Cranio-Maxillofacial Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib34","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jcms.2018.05.046","article-title":"Osteonecrosis of the jaw in patients treated with denosumab: a multicenter case series","volume":"46","author":"Aljohani","year":"2018","journal-title":"J.\u00a0Cranio-Maxillofacial Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib35","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijom.2006.02.022","article-title":"Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases","volume":"35","author":"Dimitrakopoulos","year":"2006","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib36","first-page":"1","article-title":"Drug holiday patterns and bisphosphonate-related osteonecrosis of the jaw","author":"Jung","year":"2018","journal-title":"Oral Dis."},{"key":"10.1016\/j.heliyon.2020.e03795_bib37","series-title":"AHRQ Standards","year":"2019"},{"key":"10.1016\/j.heliyon.2020.e03795_bib38","first-page":"33","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays","volume":"61","author":"Damm","year":"2013","journal-title":"Gen. Dent."},{"key":"10.1016\/j.heliyon.2020.e03795_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tripleo.2006.06.004","article-title":"Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management, Oral Surgery","volume":"102","author":"Ruggiero","year":"2006","journal-title":"Oral Med. Oral Pathol. Oral Radiol. Endodontology."},{"key":"10.1016\/j.heliyon.2020.e03795_bib40","first-page":"447","article-title":"Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer, Support","volume":"24","author":"Stopeck","year":"2016","journal-title":"Care Cancer"},{"key":"10.1016\/j.heliyon.2020.e03795_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bjoms.2008.05.011","article-title":"Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws","volume":"47","author":"Gallego","year":"2009","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.heliyon.2020.e03795_bib42","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(10)62051-X","article-title":"First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial","volume":"376","author":"Morgan","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2020.e03795_bib43","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study","volume":"19","author":"Raje","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.heliyon.2020.e03795_bib44","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1200\/JCO.2010.32.5209","article-title":"American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer","volume":"29","author":"Van Poznak","year":"2011","journal-title":"J.\u00a0Clin. Oncol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402030640X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402030640X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:55:04Z","timestamp":1773654904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402030640X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S240584402030640X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03795","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e03795"}}